Deepa S. Subramaniam, MBBS, MSc, discusses the complex and evolving treatment paradigm of BRAF- and ROS1-driven non–small cell lung cancer.
Original Article: Treatments Emerging for ROS1-, BRAF-Driven Lung Cancers